4gv2: Difference between revisions

Revision as of 05:00, 5 September 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits m Protected "4gv2" [edit=sysop:move=sysop] ← Older edit		Revision as of 20:08, 26 September 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Karlberg, T., Thorsell, A.G., Lindgren, A.E.G., Ekblad, T., Spjut, S., Andersson, C.D., Weigelt, J., Linusson, A., Elofsson, M., Schuler, H.		Authors: Karlberg, T., Thorsell, A.G., Lindgren, A.E.G., Ekblad, T., Spjut, S., Andersson, C.D., Weigelt, J., Linusson, A., Elofsson, M., Schuler, H.

	Description: ~~HUMAN~~ ARTD3 (PARP3) -~~CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR~~ ME0354		Description: Human ARTD3 (PARP3) -Catalytic domain in complex with inhibitor ME0354

Navigation menu